Organogenesis Holdings Inc. to Participate in the Cantor Fitzgerald Medical and Aesthetic Dermatology, Ophthalmology and Medtech Conference
CANTON, Mass., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that company management will participate in the Cantor Fitzgerald Medical and Aesthetic Dermatology, Ophthalmology and Medtech Conference, which is being held at The Fontainebleau Miami Beach in Miami, FL on Thursday, December 8th. The conference consists of panel discussions and 1x1 meetings with investors. Management ill participate in 1x1 meetings.
About Organogenesis Holdings Inc.
Organogenesis Holdings Inc. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics. Organogenesis’s comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs. For more information, visit www.organogenesis.com.
Investor Inquiries: ICR Westwicke Mike Piccinino, CFA [email protected] Press and Media Inquiries: Organogenesis Lori Freedman [email protected]
Cyber Insurance InfoSec Requirements: Whatâ€™s Changing, Where Do MSPs Fit In?
Keynote Presentation by ThreatLocker: Zero Trust at the Endpoint: Fighting Ransomware
Solutions Showcase TBA